The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Flinders Medical Centre, Harvard University, Dana-Farber Cancer Institute, St James's University Hospital, Sarah Cannon, Hospital de Sant Pau, Columbia University Irving Medical Center, Semmelweis University, The University of Melbourne, Peter MacCallum Cancer Centre, St Vincent's Hospital Melbourne, Universität Ulm, Vienna General Hospital, Medical University of Vienna, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Hospital Clínic de Barcelona, Verastem (United States), Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891876928